Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suk See De Ravin

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Emerging Topics in Life Sciences|February 1, 2021
CRISPR/Cas9 applications in gene therapy for primary immunodeficiency diseasesSuk See De Ravin, Julie Brault
Immunologic Research|November 4, 2008
Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment optionsSuk See De Ravin, Harry L Malech
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 29, 2008
Severe combined immunodeficiency: a national surveillance studyAnthony Yee, Suk See De Ravin, Elizabeth Elliott, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2019
Gene Editing in Chronic Granulomatous DiseaseColin L Sweeney, Randall K Merling, Suk See De Ravin, et al.
Human Gene Therapy. Clinical Development|January 21, 2015
Gene therapy studies in a canine model of X-linked severe combined immunodeficiencyPeter J Felsburg, Suk See De Ravin, Harry L Malech, et al.
The Journal of Allergy and Clinical Immunology. Global|December 4, 2025
Lymphedema in patients with X-linked severe combined immunodeficiencyFilippo Consonni, Suk See De Ravin, Stephane Vignes, et al.
Transfusion|August 22, 2014
Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiencySandhya R Panch, Yu Ying Yau, Elizabeth M Kang, et al.
Human Gene Therapy Methods|December 30, 2014
Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systemsSheng Zhou, Melissa A Bonner, Yong-Dong Wang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|February 5, 2009
Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormoneSuk See De Ravin, Elaine Shum, Kol A Zarember, et al.
Human Gene Therapy|May 29, 2010
Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoproteinToshie Sakuma, Suk See De Ravin, Jason M Tonne, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Emerging Topics in Life Sciences|February 1, 2021
CRISPR/Cas9 applications in gene therapy for primary immunodeficiency diseasesSuk See De Ravin, Julie Brault
Immunologic Research|November 4, 2008
Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment optionsSuk See De Ravin, Harry L Malech
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 29, 2008
Severe combined immunodeficiency: a national surveillance studyAnthony Yee, Suk See De Ravin, Elizabeth Elliott, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2019
Gene Editing in Chronic Granulomatous DiseaseColin L Sweeney, Randall K Merling, Suk See De Ravin, et al.
Human Gene Therapy. Clinical Development|January 21, 2015
Gene therapy studies in a canine model of X-linked severe combined immunodeficiencyPeter J Felsburg, Suk See De Ravin, Harry L Malech, et al.
The Journal of Allergy and Clinical Immunology. Global|December 4, 2025
Lymphedema in patients with X-linked severe combined immunodeficiencyFilippo Consonni, Suk See De Ravin, Stephane Vignes, et al.
Transfusion|August 22, 2014
Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiencySandhya R Panch, Yu Ying Yau, Elizabeth M Kang, et al.
Human Gene Therapy Methods|December 30, 2014
Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systemsSheng Zhou, Melissa A Bonner, Yong-Dong Wang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|February 5, 2009
Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormoneSuk See De Ravin, Elaine Shum, Kol A Zarember, et al.
Human Gene Therapy|May 29, 2010
Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoproteinToshie Sakuma, Suk See De Ravin, Jason M Tonne, et al.
Pageof 7